The short answer
Do not take multivitamins, particularly formulas containing minerals at the same time as oral alendronate. Take alendronate first, following its fasting directions. The FOSAMAX label requires at least 30 minutes before other oral products; your pharmacist can confirm the schedule for the exact supplement.
What this answer covers
Evidence concerns the alendronate active moiety in oral alendronate sodium. The label explicitly expresses sodium-salt strength as the free-acid equivalent; this does not transfer recommendations to another bisphosphonate or injectable route.
- Supplement or preparation
- multivitamin
- Medication ingredient
- alendronate
Which products does this concern?
Check the actual ingredients. Calcium, iron, magnesium and zinc can make a multivitamin relevant to the mineral warning. A shared multivitamin name does not establish the same formula or dose, and a prenatal label does not change the pregnancy restrictions of alendronate.
How should I separate the doses?
Take the alendronate dose on arising, with plain water, before the first food, drink or other oral medicine. The labeled minimum is 30 minutes afterward. It is not an interchangeable “before or after” rule: swallowing the supplement first does not satisfy the fasting directions. Follow the water and upright-position instructions supplied with the exact dosage form.
What is the evidence?
The original pharmacokinetic studies show that alendronate exposure is sensitive to food and beverages. Current prescribing information supplies the mineral and antacid precaution. The evidence does not provide a reliable interaction percentage for each individual supplement formulation.
Evidence and practical considerations
Timing & monitoring
Do not take multivitamins, particularly formulas containing minerals at the same time as oral alendronate. Take alendronate first, following its fasting directions. The FOSAMAX label requires at least 30 minutes before other oral products; your pharmacist can confirm the schedule for the exact supplement.
- Exact scope
- Multivitamin taken orally; exact composition must be checked. with Evidence concerns the alendronate active moiety in oral alendronate sodium. The label explicitly expresses sodium-salt strength as the free-acid equivalent; this does not transfer recommendations to another bisphosphonate or injectable route.
- Medication form and route
- oral alendronate sodium tablets or labeled oral solution
- Timing or duration
- Alendronate first after an overnight fast; at least 30 minutes before the supplement. No universal 60-minute minimum was established.
What remains uncertain
- Label-based applicability to the specified oral product; an isolated clinical effect size for this exact supplement was not established in the retrieved primary studies. Do not interpret dose separation as a guarantee or generalize to injectable preparations.
Factors that may matter: exact supplement ingredients; fasting administration; dosage form.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients using oral alendronate sodium for labeled bone conditions.
Requires fasting administration with plain water and at least 30 minutes before other oral products; warns about calcium, antacids and multivalent cations; supports adequate calcium and vitamin D.
How this applies: Active-moiety bridge is explicit in the alendronate sodium label. The source supports the described oral-product precaution or context, not a measured interaction magnitude for every multivitamin formulation.
Product-specific labeling; does not quantify an interaction for every mineral salt or supplement brand.
Source 2: primary clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Primarily postmenopausal women; one study in men.
Food and beverages altered drug exposure; the investigators supported fasting administration at least 30 minutes before food or drink.
How this applies: Supports the specific multivitamin discussion; retain the study/formulation limits stated above.
Abstract only; does not supply an isolated effect for each mineral product. Pharmacokinetic outcomes do not quantify fracture risk.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original sources checked; exact preparation and timing limits assessed; consumer article drafted and existing checker statements reconciled. | |
| Research summary published |
Article revision: 5738449e26234fe6
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.